Invention Grant
- Patent Title: Use of low dose IL-2 for treating autoimmune—related or inflammatory disorders
-
Application No.: US16361902Application Date: 2019-03-22
-
Publication No.: US10765723B2Publication Date: 2020-09-08
- Inventor: David Klatzmann , David Saadoun , Patrice Cacoub , Michèle Rosenzwajg , Eliane Piaggio , Gilbert Bensimon , Claude Bernard
- Applicant: INSERM (Institut National de la Santé et de la Recherche Médicale) , Assistance Publique—Hopitaux De Paris , SORBONNE UNIVERSITE
- Applicant Address: FR Paris FR Paris FR Paris
- Assignee: INSERM (Institut National de la Santé et de la Recherche Médicale,Assistance Publique—Hopitaux De Paris,SORBONNE UNIVERSITE
- Current Assignee: INSERM (Institut National de la Santé et de la Recherche Médicale,Assistance Publique—Hopitaux De Paris,SORBONNE UNIVERSITE
- Current Assignee Address: FR Paris FR Paris FR Paris
- Agency: Polsinelli PC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@47970628
- Main IPC: A61K38/20
- IPC: A61K38/20
Abstract:
The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.
Public/Granted literature
- US20190351023A1 USE OF LOW DOSE IL-2 FOR TREATING AUTOIMMUNE - RELATED OR INFLAMMATORY DISORDERS Public/Granted day:2019-11-21
Information query
IPC分类:
